The latest research study “Local Anesthesia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global local anesthesia drugs market size reached US$ 2.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.62 Billion by 2027 exhibiting a growth rate (CAGR) of 4.30% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Industry Definition and Application:
Local anesthesia drugs refer to chemical compounds producing anesthesia by impeding the excitation of nerve endings or intercepting conduction in peripheral nerves. They are typically available as topical creams or administered through injections or sprays during biopsies, dental care, minor surgeries, labor and delivery, obstetrical procedures, etc. Local anesthesia drugs treat painful conditions, such as sore throat and mouth ulcers, and relieve itching caused by minor burns, cuts, scratches, insect bites, and poison ivy. They also assist in effective and rapid pain relief during esophagitis, hiatus hernia, gastritis, and heartburn of peptic ulcer.
Request a free sample brochure: https://www.imarcgroup.com/local-anesthesia-drugs-market/requestsample
Local Anesthesia Drugs Market Trends and Drivers:
The escalating prevalence of cardiovascular, respiratory, and other chronic diseases that need several procedures, including laparoscopic colectomy, laparoscopic hysterectomy, cochlear implantation, secondary hip replacement, and knee replacement, is primarily driving the local anesthesia drugs market.
Besides this, the growing geriatric population undergoing surgical interventions requiring post-operative pain relief is further augmenting the market growth. Moreover, the rising number of dental surgeries and the introduction of novel and effective medicines, such as articaine, levobupivacaine, and ropivacaine, are also catalyzing the global market.
Apart from this, the elevating demand for minimally invasive (MI) cosmetic surgical procedures, including botulinum toxin and facial filler injections, owing to the increasing consciousness about physical appearance among individuals, is acting as another significant growth-inducing factor. Furthermore, the development in healthcare infrastructure and the expanding medical tourism activities are expected to bolster the local anesthesia drugs market in the coming years.
|
Long Term Care Market Report Scope |
|
|
Report Coverage |
Details |
|
Market size value in 2021 |
US$ 947.94 Billion |
|
Market forecast in 2027 |
US$ 1,399.62 Billion |
|
Growth Rate |
CAGR of 6.50% from 2022 to 2027 |
|
Base year for estimation |
2021 |
|
Historical data |
2016-2021 |
|
Forecast period |
2022-2027 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Service, Gender and Payer |
|
Regional scope |
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
|
Key companies profiled |
Amedisys Inc., Atria Senior Living Inc. (Wickshire Senior Living), Brookdale Senior Living Inc., Diversicare Healthcare Services Inc., Extendicare Inc., Genesis HealthCare, Home Instead Inc. (Honor Technology Inc.), Kindred Healthcare (LifePoint Health Inc.), LHC Group Inc. (UnitedHealth Group Incorporated), Sonida Senior Living Corporation, Sunrise Senior Living (Revera Inc.) and Trinity Health |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization preview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Drug Type:
• Lidocaine
• Bupivacaine
• Benzocaine
• Ropivacaine
• Prilocaine
• Chloroprocaine
• Others
Breakup by Mode of Administration:
• Injectables
• Surface Anesthetic
Breakup by Distribution Channel:
• Hospital Pharmacy
• Pharmacy Stores
• Others
Click here to view detailed information with table of content: https://www.imarcgroup.com/local-anesthesia-drugs-market
By Geography:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa
List of Major Key Players:
The major players in the market are Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Baxter International Inc., Endo International plc, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Pacira Biosciences Inc., Pfizer Inc., Pierrel S.p.A. and Septodont.
Browse Other Related Report:
Insomnia Market Size: https://www.imarcgroup.com/insomnia-market
Home Medical Equipment Market 2022-2027: https://www.imarcgroup.com/home-medical-equipment-market
IVF Devices and Consumables Market Share: https://www.imarcgroup.com/ivf-devices-consumables-market
Anesthesia CO2 Absorbent Market Forecast: https://www.imarcgroup.com/anesthesia-co2-absorbent-market
Vaccine Delivery Devices Market Size: https://www.imarcgroup.com/vaccine-delivery-devices-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
